Invention Grant
- Patent Title: Methods of use for TRP channel antagonist-based combination cancer therapies
-
Application No.: US16491752Application Date: 2018-03-05
-
Publication No.: US11241442B2Publication Date: 2022-02-08
- Inventor: Joan Siefert Brugge , Nobuaki Takahashi
- Applicant: President and Fellows of Harvard College
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Clark & Elbing LLP
- International Application: PCT/US2018/020937 WO 20180305
- International Announcement: WO2018/165034 WO 20180913
- Main IPC: A61K31/555
- IPC: A61K31/555 ; A61P35/00 ; A61K45/06 ; C12N15/113
Abstract:
The present invention relates to methods for treating cancer through combination therapy with a TRP channel antagonist and standard-of-care cancer agents.
Public/Granted literature
- US20210128581A1 METHODS OF USE FOR TRP CHANNEL ANTAGONIST-BASED COMBINATION CANCER THERAPIES Public/Granted day:2021-05-06
Information query
